Freedom of Information Act Requests (FOIA)
Improving Disclosure of Information Summary
Public Liaison: This position is currently vacant.
FOIA Requestor Center: This position is currently vacant.
Chief FOIA Officer: Jeffrey Teitz (202) 395-6601
How to Make a FOIA Request to the ONDCP
A request made under the FOIA must be submitted in writing, by mail or fax, to the following address:
Office of Legal Counsel
Attn: General Counsel
750 17th Street, N.W.
Washington, D.C. 20503
Phone: (202) 395-6622
Fax: (202) 395-5543
Archived FOIA Reports
- FY' 12 Report (PDF)
- FY' 12 Report (XML)
- FOIA Cheif Officer Report 2013
- FY' 11 Report(PDF)
- FY' 11 Report(XML)
- FY’ 10 Report
- FY’ 09 Report
- FY’ 08 Report
- FY’ 07 Report
- FY’ 06 Report
- FY’ 05 Report
- FY’ 04 Report
- FY’ 03 Report
- FY’ 02 Report
- FY’ 01 Report
- FY’ 00 Report
- FY’ 99 Report
- FY’ 98 Report
- FY' 97 Report
Chief FOIA Officer’s Report
Pursuant to the Federal Activities Inventory Reform Act (FAIR), be advised that the Office of National Drug Control Policy (ONDCP) does not perform any commercial activities by in-house employees.
Information Quality Guidelines
The Office of National Drug Control Policy publishes these guidelines in accordance with the Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information disseminated by Federal Agencies (Government-wide guidelines) published in interim final form by OMB in the Federal Register in Volume 66, No. 189 at 49718 on Friday, September 8, 2001, and in final form in Volume 2, No. 67 at 8452 on February 2, 2002.
Guide to Unsolicited Proposals
ONDCP strongly encourages potential offerors to participate in the preliminary process before expending time or money preparing an Unsolicited Proposal.
- Public Financial Disclosure (SF 278) Process
- Confidential Financial Disclosure Report (SF 450) Process
ONDCP currently falls under the Executive Office of the President procedures for classified information declassification. These procedures are in accordance with Executive Order 13526, PART 3 -- DECLASSIFICATION AND DOWNGRADING (December 29, 2009).
For additional questions regarding FOIA, please visit the contact us page.
Neither ONDCP nor its Director and staff endorse any commercial drug control product.